Comparison study of AMH levels and BMI in polycystic ovary syndrome patients

Kadhem Fakher And Samah Amer Hammood, Nadia

	Comparison study of AMH levels and BMI in polycystic ovary syndrome patients
Al-Kunooze Scientific Journal
Volume 11, Issue 2, April 2025, Pages 55-61 PDF (377.65 K)
Document Type: Original Article
Author
Nadia Kadhem fakher and Samah Amer Hammood
Abstract
The ovarian follicles generate the hormone known as AMH (Anti-Müllerian hormone). The hormone AMH shows higher levels in patients who have polycystic ovary syndrome (PCOS). The research investigates the connection between AMH hormone levels in PCOS patients through hormone analysis of women with the syndrome versus a control group. AMH levels are measured to assess the ovary's capacity to generate eggs, which is advantageous for reproductive treatments, and to diagnose PCOS by identifying an increased number of tiny follicles. The current study included 90 Iraqi women (aged 18-40 years): 46 with PCOS and a control group of 44 healthy women. Blood samples were taken from the study participants to evaluate the levels of certain hormones, including AMH, LH, E2, insulin. Blood samples were collected during the early follicular phase of the menstrual cycle (days 2–5) to ensure hormonal consistency. The following parameters were studied: AMH levels were significantly elevated in both normal weight and overweight/obese PCOS women compared to their respective control groups. This is a hallmark of PCOS, reflecting increased ovarian follicle count. AMH levels (ng/ml) were significantly higher in women with PCOS compared to normal weight controls (p = 0.015), indicating a strong association between elevated AMH and PCOS
Keywords
Polycystic ovary syndrome; BMI; Hormone disorder; AMH

Statistics Article View: 68 PDF Download: 20